Your browser doesn't support javascript.
loading
Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults.
Fiebelkorn, Amy Parker; Coleman, Laura A; Belongia, Edward A; Freeman, Sandra K; York, Daphne; Bi, Daoling; Kulkarni, Ashwin; Audet, Susette; Mercader, Sara; McGrew, Marcia; Hickman, Carole J; Bellini, William J; Shivakoti, Rupak; Griffin, Diane E; Beeler, Judith.
Affiliation
  • Fiebelkorn AP; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Coleman LA; Marshfield Clinic Research Foundation, Wisconsin.
  • Belongia EA; Marshfield Clinic Research Foundation, Wisconsin.
  • Freeman SK; Marshfield Clinic Research Foundation, Wisconsin.
  • York D; Marshfield Clinic Research Foundation, Wisconsin.
  • Bi D; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Kulkarni A; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring.
  • Audet S; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring.
  • Mercader S; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • McGrew M; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Hickman CJ; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Bellini WJ; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Shivakoti R; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Griffin DE; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Beeler J; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring.
J Infect Dis ; 213(7): 1115-23, 2016 Apr 01.
Article in En | MEDLINE | ID: mdl-26597262
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Measles-Mumps-Rubella Vaccine / Antibodies, Neutralizing / Immunity, Cellular / Measles virus / Antibodies, Viral Type of study: Etiology_studies / Incidence_studies / Observational_studies / Qualitative_research / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: J Infect Dis Year: 2016 Document type: Article Affiliation country: Georgia Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Measles-Mumps-Rubella Vaccine / Antibodies, Neutralizing / Immunity, Cellular / Measles virus / Antibodies, Viral Type of study: Etiology_studies / Incidence_studies / Observational_studies / Qualitative_research / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: J Infect Dis Year: 2016 Document type: Article Affiliation country: Georgia Country of publication: United States